Carlo A. Cervical cancer is relatively rare in high-income countries, where organized screening programs are in place, as well as opportunistic ones. As the human papillomavirus HPV vaccination rates increase, the prevalence of cervical precancers and cancers is going to decrease rapidly very soon, even if, in the most optimistic scenario, it is unlikely that optimal vaccination coverage will be achieved. Then, the optimal screening paradigm for cervical cancer prevention in the postvaccination era is still debated. Screening guidelines are being developed with the aim of reducing the number of tests a woman needs during her lifetime, in order to receive the maximum benefit from screening, while decreasing potential harms that may result with the use of a screening strategy overdiagnosis, overtreatment, anxiety, and costs. With this purpose in mind, new management guidelines for cervical cancer screening abnormalities are recommendations based on risks, not on results.
A grey literature review of special events for promoting cancer screenings
Colorectal cancer, screening and primary care: A mini literature review
Colorectal cancer CRC is a common health problem, representing the third most commonly diagnosed cancer worldwide and causing a significant burden in terms of morbidity and mortality, with annual deaths estimated at The western way of life, that is being rapidly adopted in many regions of the world, is a well discussed risk factor for CRC and could be targeted in terms of primary prevention. Furthermore, the relatively slow development of this cancer permits drastic reduction of incidence and mortality through secondary prevention. These facts underlie primary care physicians PCPs being assigned a key role in health strategies that enhance prevention and prompt diagnosis.
Literature Review : Cervical Cancer
Prostate cancer is the most commonly diagnosed non-skin cancer in men. Screening for prostate cancer is widely accepted; however concerns regarding the harms outweighing the benefits of screening exist. Electronic databases and reference lists were searched to October Sixty studies involving 3, men aged from 18—89 years, who had been screened for prostate cancer by Prostate Specific Antigen PSA or Digital Rectal Examination DRE and not screened, across eight countries were included.
To browse Academia. Skip to main content. Log In Sign Up. Download Free PDF. Inequalities of access to cancer screening: a literature review